Corient Capital Partners’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
Other funds holding XYL
PAMS
Corient Capital Partners's XYL Position: Q3 2022 in Review
Corient Capital Partners increased its Xylem (XYL) stake by 0.01% in Q3 2022, buying an estimated $91 and bringing the position to 8,587 shares worth $671K. The position accounts for 0.05% of the portfolio, ranked #279.
Corient Capital Partners first reported a position in XYL in Q1 2020 and has held it in 11 quarters since. The position peaked at $1.19M in Q3 2021. 740 funds tracked by Wall St. Rank hold XYL as of Q3 2022.
- Corient Capital Partners held 8,587 shares of Xylem worth $671K as of Q3 2022.
- Corient Capital Partners bought 1 Xylem share in Q3 2022, an estimated $91.
- Xylem made up 0.05% of Corient Capital Partners's portfolio in Q3 2022, its #279 holding.
- Corient Capital Partners first reported a position in Xylem in Q1 2020 and has held it in 11 quarters since.
- Corient Capital Partners's Xylem position peaked at $1.19M in Q3 2021.
- 740 funds tracked by Wall St. Rank held Xylem as of Q3 2022.
Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.